Hara Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Buy
9,956
+92
+0.9% +$30.2K 1.45% 21
2025
Q4
$3.46M Sell
9,864
-620
-6% -$210K 1.92% 12
2025
Q3
$3.39M Buy
+10,484
New +$3.26M 2% 11

Other funds holding ELV

Hara Capital's ELV Position: Q1 2026 in Review

Hara Capital increased its Elevance Health (ELV) stake by 0.93% in Q1 2026, buying an estimated $30.2K and bringing the position to 9,956 shares worth $2.91M. The position accounts for 1.45% of the portfolio, ranked #21.

Hara Capital first reported a position in ELV in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.46M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Hara Capital held 9,956 shares of Elevance Health worth $2.91M as of Q1 2026.
  • Hara Capital bought 92 Elevance Health shares in Q1 2026, an estimated $30.2K.
  • Elevance Health made up 1.45% of Hara Capital's portfolio in Q1 2026, its #21 holding.
  • Hara Capital first reported a position in Elevance Health in Q3 2025 and has held it in 3 quarters since.
  • Hara Capital's Elevance Health position peaked at $3.46M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.